Ophthalmology

Top Story

Remembering the pioneering work and life of George O. Waring III

Remembering the pioneering work and life of George O. Waring III
July 29, 2016

George Oral Waring III, MD, FACS, FRCOphth, pioneering refractive surgeon and life enthusiast, died in January 2015 at the age of 73. His contribution to ophthalmology and particularly refractive surgery was only paralleled by his dedication to scientific publication and the relentless mentoring of successive generations of academic clinicians; Waring made a tremendous impact on ophthalmology worldwide. His vivacious spirit and genuine delight in the achievements of others left a mark on all who met him.

Publication Exclusive — Unsung heroes of dry eye care: Technicians make or break a dry eye clinic

July 29, 2016
The other day I was hanging around “Sky Bar,” the tech station at SkyVision. Do you have kids? When I am quietly standing there, I am kind of like the parent…

Xiidra first FDA-approved drug for signs and symptoms of dry eye disease

July 28, 2016
The FDA approved Xiidra for the treatment of signs and symptoms of dry eye disease in adult patients on July 11. Manufactured by Shire, Xiidra (lifitegrast ophthalmic…
FDA News

CenterVue launches training module to aid low vision patients

July 28, 2016
CenterVue announced 510(k) clearance for its fixation training for the MAIA platform, a technology designed to help patients rehabilitate from vision loss using audio…

pSivida’s Medidur maintains primary endpoint results at 12 months

July 28, 2016
Medidur statistically significantly prevented recurrence of posterior uveitis through 12 months, pSivida announced in a press release. Prevention of recurrence of…
More News Headlines »
Clinical Science

Optical Coherence Tomography Angiography Findings in Coats' Disease

Ophthalmic Surgery, Lasers and Imaging Retina, July 2016, Volume 47 Issue 7
To describe optical coherence tomography angiography (OCTA) findings in patients with unilateral Coats' disease…
More »
CME

Clinical Trials in Diabetic Retinopathy

This activity is supported by educational grants from Allergan, Inc.; Genentech, Inc.; and Regeneron Pharmaceuticals, Inc.

The advent of intravitreal therapies to treat retinal diseases has revolutionized the management of retinal pathology…
More »
Featured
Highlights from ASCRS

Highlights from ASCRS

Video
Meeting News Coverage

VIDEO: Speaker gives update on infectious uveitis

July 23, 2016
More »
morganatic-roan